![Christopher Peetz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Peetz
Founder at
MIRUM PHARMACEUTICALS, INC.
Net worth: 46 M $ as of 2026-07-30
Profile
Christopher Peetz is the founder of Mirum Pharmaceuticals, Inc., founded in 2018, serving as Chief Executive Officer & Director.
Current jobs include Chief Executive Officer at Satiogen Pharmaceuticals, Inc. and Independent Director at Arcutis Biotherapeutics, Inc. starting in 2026.
Former jobs include Chief Executive Officer at Flashlight Therapeutics, Inc. from 2017 to 2019; Senior Director-Corporate Development & Strategy at Onyx Pharmaceuticals, Inc. from 2007 to 2012; Independent Director at Alpine Immune Sciences, Inc. from 2018 to 2024; Principal at TerraVia Holdings, Inc.; Vice President-Finance & Development at SillaJen Biotherapeutics, Inc. from 2012 to 2014; and Chief Financial Officer & Head-Development at Tobira Therapeutics, Inc. from 2014 to 2016.
Education includes undergraduate studies at Washington University in St. Louis and an MBA from Stanford Graduate School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-09 | 381,809 ( 0.63% ) | 40 M $ | 2026-07-30 | |
| 2026-07-14 | 191,815 ( 0.15% ) | 5 M $ | 2026-07-30 |
Christopher Peetz active positions
| Companies | Position | Start |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Founder | 2018-05-06 |
| ARCUTIS BIOTHERAPEUTICS, INC. | Director/Board Member | 2026-07-14 |
Satiogen Pharmaceuticals, Inc.
 Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Chief Executive Officer | - |
Former positions of Christopher Peetz
| Companies | Position | End |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Director/Board Member | 2024-05-19 |
Flashlight Therapeutics, Inc.
 Flashlight Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for unmet medical needs | Chief Executive Officer | 2019-04-30 |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Director of Finance/CFO | 2016-11-30 |
| TOBIRA THERAPEUTICS INC | Director of Finance/CFO | 2016-11-30 |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company provides clinical research and development services | Corporate Officer/Principal | 2014-02-28 |
Training of Christopher Peetz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
TerraVia Holdings, Inc.
 TerraVia Holdings, Inc. Household/Personal CareConsumer Non-Durables Manufactures and sells food, nutrition and specialty ingredients from algae | Consumer Non-Durables |
SillaJen Biotherapeutics, Inc.
SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company provides clinical research and development services | Commercial Services |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Health Technology |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Commercial Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Flashlight Therapeutics, Inc.
Flashlight Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for unmet medical needs | Health Technology |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
- Stock Market
- Insiders
- Christopher Peetz
